(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EQUIL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

EQUIL

ST13

US500000079276031

Class

10

Filing

79276031

Registration

6450816

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

43

Latest update

08/17/2026

Trademark type

Combined

Nice classes

10

Filing date

12/10/2019

Registration date

08/17/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/17/2021

Last transaction

08/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

CN

Examiner

REID, CAILE MAUREEN

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "EQUIL" with the letters "E" and "Q" contained within two touching and staggered rectangles standing vertically with rounded edges, with the "E" being at the bottom of a rectangle and lined up with the letter "Q" at the top of the other rectangle.

Holders and representatives

Holders

MICROTECH MEDICAL (HANGZHOU) CO.,LTD.

Representatives

Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Catheters; vacuum pumps for medical purposes; blood testing apparatus; hypodermic syringes; medical apparatus and instruments for use in monitoring and controlling blood sugar levelsa patch insulin pump system; trocars; syringes for medical purposes; Apparatus for use in medical analysisinsulin infusion pumpsalso comprising diagnostic instruments for the analysis of blood glucose levelssold as a unit; testing apparatus for medical purposesapparatus for monitoring and controlling blood glucose levelsin particular with the use of bolus and basal insulin infusionsblood glucose testingbolus infusion size calculations; diagnostic apparatus for medical purposesinsulin delivery diagnostic apparatus for detecting low blood glucose levelsinsulin infusion diagnostic apparatus for monitoring blood glucose levels

Publications

History of USPTO decisions and trademark events.

43 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/17/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/21/2022

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

01/25/2022

XXCR

GENERIC MADRID TRANSACTION CREATED

01/25/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/17/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/21/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/17/2021

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/04/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/09/2021

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

06/09/2021

GPNX

NOTIFICATION PROCESSED BY IB

06/07/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/01/2021

PUBO

PUBLISHED FOR OPPOSITION

06/01/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/12/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/12/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/12/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/27/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

04/27/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/27/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

04/27/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/27/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/22/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/22/2021

ALIE

ASSIGNED TO LIE

04/19/2021

ALIE

ASSIGNED TO LIE

04/07/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/07/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/10/2020

GNSL

LETTER OF SUSPENSION E-MAILED

06/10/2020

CNSL

SUSPENSION LETTER WRITTEN

06/10/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/21/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/21/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/21/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/21/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/21/2020

RFNT

REFUSAL PROCESSED BY IB

04/17/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/02/2020

RFRR

REFUSAL PROCESSED BY MPU

04/02/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/19/2020

CNRT

NON-FINAL ACTION WRITTEN

03/18/2020

DOCK

ASSIGNED TO EXAMINER

03/10/2020

MAFR

APPLICATION FILING RECEIPT MAILED

01/14/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/10/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/09/2020

Continuous trademark protection

Get notified about every new filing that threatens EQUIL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.